analgezia si anestezia in obstetrica. analgezia in travaliu - anestezie ...
analgezia si anestezia in obstetrica. analgezia in travaliu - anestezie ...
analgezia si anestezia in obstetrica. analgezia in travaliu - anestezie ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Obstetrică<br />
264<br />
Antiepileptice<br />
Medicament Sapt.<br />
1-12<br />
Acid valproic (valporat<br />
de sodiu)<br />
Barbiturice (fenobarbital)<br />
Sapt.<br />
13-39<br />
Per<strong>in</strong>atal<br />
Lactatie Observatii<br />
(-) (-) (-) + Scade eficacitatea contraceptivelor<br />
estroprogestative<br />
-- (+) (+) +<br />
Fenito<strong>in</strong>a (+) (+) (+) +<br />
Carbamazep<strong>in</strong>a -- -- -- (+)<br />
Benzodiazep<strong>in</strong>a<br />
(diazepam, clonazepam)<br />
(-) (-) -- diazepam<br />
IV de<br />
electie<br />
<strong>in</strong> status<br />
epilecticus<br />
Medicamente utilizate <strong>in</strong> gastroenterologie<br />
Medicament Sapt.<br />
1-12<br />
Antagonistii<br />
receptorilor H2<br />
(ranitid<strong>in</strong>a)<br />
Inhibitor de pompa<br />
Na/K<br />
Omeprazol, Lansoprazol,Pantoprazol,<br />
Esomeprazol<br />
Antiacide (Sucralfat)<br />
Sapt.<br />
13-39<br />
Per<strong>in</strong>atal<br />
(cu exceptia valporatului de<br />
sodiu)<br />
Sfat preconceptional<br />
util datorita riscului de<br />
malformatii fetale (buza<br />
de iepure, cardiopatii – <strong>in</strong><br />
cazul fenobarbitalului <strong>si</strong><br />
fenito<strong>in</strong>ei; sp<strong>in</strong>a bifida – <strong>in</strong><br />
cazul valporatului de sodiu;<br />
malformatii cranio faciale<br />
hipoplazie unighiara <strong>si</strong> faciala,<br />
retard mental)<br />
Se va efectua ecografie<br />
fetala optim <strong>in</strong>tre a 18 <strong>si</strong><br />
20 saptamana de sarc<strong>in</strong>a<br />
pentru depistarea acestor<br />
malformatii<br />
Absenta manifestarilor<br />
convul<strong>si</strong>ve cativa ani <strong>in</strong>a<strong>in</strong>tea<br />
sarc<strong>in</strong>ii poate constitui o<br />
<strong>in</strong>dicatie de sevraj<br />
adm<strong>in</strong>istrarea valporatului<br />
justifica amniocenteza la 16<br />
18 saptamani <strong>si</strong> dozarea α<br />
fetoprote<strong>in</strong>ei <strong>si</strong> a acetilcol<strong>in</strong>esterazei<br />
<strong>in</strong> lichidul<br />
amniotic. Pentru prevenirea<br />
complicatiilor hemoragice<br />
la nou nascut se vor asocia<br />
vitam<strong>in</strong>a k1 vitam<strong>in</strong>a D <strong>si</strong><br />
acid folic<br />
Clasa FDA D<br />
Lactatie Observatii<br />
-- -- -- -- Risc de fem<strong>in</strong>izare a fatului<br />
de sex mascul<strong>in</strong><br />
Clasa FDA B<br />
+ + + + Fara risc teratogen<br />
Clasa FDA B<br />
-- (+) (+) + Clasa FDA B<br />
Laxative (+) (+) (+) (+)<br />
Antidiareice (+) (+) (+) (+)